HomeNewsNeuroscienceMigraine

  • Dextromethorphan displays efficacy in Prophylactic Migraine treatment for patients with MS

    • April 3, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • NDA filing of Acute Migraine Treatment by Dr. Reddy’s Laboratories and Promius Pharma

    • April 2, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • sTMS Device can prevent Migraine attacks, claims a recent observational study

    • April 2, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Acute Migraine treatment Rimegepant successfully achieves Co-Primary Endpoints in two pivotal Phase 3 Trials

    • March 26, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Low risk of serotonin syndrome associated with concomitant use of triptans and SSRIs or SNRIs, finds latest study

    • March 24, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Alder stock suffers after CEO exits months before major drug filing in Migraine

    • March 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Acute Migraine treatment ZYDIS® ODT enrolls first patient in Ph 3 clinical trial

    • March 21, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more